230 related articles for article (PubMed ID: 22975570)
1. Drug-induced acute interstitial nephritis mimicking acute tubular necrosis after initiation of tenofovir-containing antiretroviral therapy in patient with HIV-1 infection.
Nishijima T; Yazaki H; Hinoshita F; Tasato D; Hoshimoto K; Teruya K; Gatanaga H; Kikuchi Y; Oka S
Intern Med; 2012; 51(17):2469-71. PubMed ID: 22975570
[TBL] [Abstract][Full Text] [Related]
2. Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies.
Schmid S; Opravil M; Moddel M; Huber M; Pfammatter R; Keusch G; Ambuhl P; Wuthrich RP; Moch H; Varga Z
Virchows Arch; 2007 Jun; 450(6):665-70. PubMed ID: 17464512
[TBL] [Abstract][Full Text] [Related]
3. Delayed onset renal failure in a patient on tenofovir based antiretroviral regimen.
Krishna MM; Subbalaxmi MV; Uppin M; Radhika S
Indian J Pharmacol; 2014; 46(2):230-1. PubMed ID: 24741201
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.
Herlitz LC; Mohan S; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
Kidney Int; 2010 Dec; 78(11):1171-7. PubMed ID: 20811330
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy.
Perazella MA
Kidney Int; 2010 Dec; 78(11):1060-3. PubMed ID: 21076445
[TBL] [Abstract][Full Text] [Related]
6. Urinary beta-2 microglobulin and alpha-1 microglobulin are useful screening markers for tenofovir-induced kidney tubulopathy in patients with HIV-1 infection: a diagnostic accuracy study.
Nishijima T; Shimbo T; Komatsu H; Takano M; Tanuma J; Tsukada K; Teruya K; Gatanaga H; Kikuchi Y; Oka S
J Infect Chemother; 2013 Oct; 19(5):850-7. PubMed ID: 23467792
[TBL] [Abstract][Full Text] [Related]
7. Severe recurrent rhabdomyolysis-induced acute kidney injury in a HIV-infected patient on antiretroviral therapy.
Spiegel LR; Schrier PB; Shah HH
Ren Fail; 2013 Sep; 35(8):1186-90. PubMed ID: 23883141
[TBL] [Abstract][Full Text] [Related]
8. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
Andrade-Fuentes K; Mata-Marín JA; López-De León JI; Manjarrez-Téllez B; Ramírez JL; Gaytan-Martínez J
AIDS Patient Care STDS; 2015 Apr; 29(4):181-5. PubMed ID: 25101526
[TBL] [Abstract][Full Text] [Related]
9. Acute tubular necrosis in a patient receiving tenofovir.
Lee JC; Marosok RD
AIDS; 2003 Nov; 17(17):2543-4. PubMed ID: 14600530
[No Abstract] [Full Text] [Related]
10. Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration.
Bickel M; Khaykin P; Stephan C; Schmidt K; Buettner M; Amann K; Lutz T; Gute P; Haberl A; Geiger H; Brodt HR; Jung O
HIV Med; 2013 Nov; 14(10):633-8. PubMed ID: 23980564
[TBL] [Abstract][Full Text] [Related]
11. Tenofovir-related acute kidney injury and proximal tubule dysfunction precipitated by diclofenac: a case of drug-drug interaction.
Morelle J; Labriola L; Lambert M; Cosyns JP; Jouret F; Jadoul M
Clin Nephrol; 2009 May; 71(5):567-70. PubMed ID: 19473619
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy.
Dauchy FA; Lawson-Ayayi S; de La Faille R; Bonnet F; Rigothier C; Mehsen N; Miremont-Salamé G; Cazanave C; Greib C; Dabis F; Dupon M
Kidney Int; 2011 Aug; 80(3):302-9. PubMed ID: 21544066
[TBL] [Abstract][Full Text] [Related]
13. Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients.
Calza L; Trapani F; Tedeschi S; Piergentili B; Manfredi R; Colangeli V; Viale P
Scand J Infect Dis; 2011 Aug; 43(8):656-60. PubMed ID: 21453205
[TBL] [Abstract][Full Text] [Related]
14. Acute kidney injury as a presentation of primary renal diffuse large B-cell lymphoma in HIV.
Hughes DJ; Fitzgerald N; Sran H; Konig M; Moore-Moffatt R; Webb A; Gilleece Y; Churchill DR
Int J STD AIDS; 2014 Apr; 25(5):380-2. PubMed ID: 24047882
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of tenofovir treatment.
Rodriguez-Novoa S; Labarga P; Soriano V
Pharmacogenomics; 2009 Oct; 10(10):1675-85. PubMed ID: 19842939
[TBL] [Abstract][Full Text] [Related]
16. Fanconi syndrome-like tubular acidosis associated with a tenofovir-containing antiretroviral regimen in a human immunodeficiency virus-1-infected Asian woman.
Kiyasu Y; Koganemaru H; Hitomi S
J Infect Chemother; 2012 Apr; 18(2):255-7. PubMed ID: 21918819
[TBL] [Abstract][Full Text] [Related]
17. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.
Gafni RI; Hazra R; Reynolds JC; Maldarelli F; Tullio AN; DeCarlo E; Worrell CJ; Flaherty JF; Yale K; Kearney BP; Zeichner SL
Pediatrics; 2006 Sep; 118(3):e711-8. PubMed ID: 16923923
[TBL] [Abstract][Full Text] [Related]
18. ASN clinical pathological conference. Tenofovir-related ATN (severe).
Atta MG; Stokes MB
Clin J Am Soc Nephrol; 2013 May; 8(5):882-90. PubMed ID: 23371959
[No Abstract] [Full Text] [Related]
19. Experience with tenofovir disoproxil fumarate for antiretroviral therapy.
Stephan C
Expert Opin Pharmacother; 2008 May; 9(7):1197-209. PubMed ID: 18422476
[TBL] [Abstract][Full Text] [Related]
20. Recurrent bone fractures due to tenofovir-induced renal phosphate wasting.
Koenig KF; Kalbermatter S; Menter T; Graber P; Kiss D
Scand J Infect Dis; 2014 Mar; 46(3):221-4. PubMed ID: 24147545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
